A detailed history of Crewe Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Crewe Advisors LLC holds 791 shares of VTRS stock, worth $8,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
791
Previous 791 -0.0%
Holding current value
$8,898
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$10.05 - $12.02 $60 - $72
-6 Reduced 0.75%
791 $8,000
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $597 - $717
-53 Reduced 6.24%
797 $9,000
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $517 - $640
59 Added 7.46%
850 $9,000
Q2 2023

Jul 28, 2023

SELL
$9.02 - $10.29 $1,461 - $1,666
-162 Reduced 17.0%
791 $7,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $1,922 - $2,562
-209 Reduced 17.99%
953 $9,000
Q4 2022

Feb 07, 2023

SELL
$8.72 - $11.56 $1,534 - $2,034
-176 Reduced 13.15%
1,162 $12,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $1,492 - $1,958
176 Added 15.15%
1,338 $11,000
Q2 2022

Aug 02, 2022

BUY
$9.95 - $12.27 $1,900 - $2,343
191 Added 19.67%
1,162 $12,000
Q1 2022

Apr 27, 2022

BUY
$9.81 - $15.4 $4,355 - $6,837
444 Added 84.25%
971 $11,000
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $531 - $645
44 Added 9.11%
527 $7,000
Q3 2021

Oct 29, 2021

SELL
$13.25 - $15.13 $3,445 - $3,933
-260 Reduced 34.99%
483 $7,000
Q2 2021

Aug 11, 2021

SELL
$12.97 - $16.15 $3,216 - $4,005
-248 Reduced 25.03%
743 $11,000
Q1 2021

Apr 21, 2021

BUY
$13.59 - $18.54 $258 - $352
19 Added 1.95%
991 $14,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $13,899 - $18,215
972 New
972 $18,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.